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POEMS (polyneuropathy, organomegaly, endo-crinopathy, M-protein, and skin changes) syn-drome, also known as osteosclerotic myeloma, 
Craw-Fukase syndrome, or Takasuki syndrome, is a rare 
paraneoplastic syndrome caused by an underlying plas-
maproliferative disorder with multiorgan involvement 
due to capillary leak syndrome and thromoembolic 
events, resulting in a poor prognosis.1-3 Consistent plas-
ma cell disorders include a monoclonal component, of-
ten in small quantities with a lambda light chain isotype, 
and plasmacytoma, often solitary lesions. The patho-
genesis of POEMS syndrome is not well understood, 
but overproduction of vascular endothelial growth fac-
tor (VEGF), probably secreted by plasmacytoma, may 
be responsible for most of its characteristic symptoms.4 
Treatment depends on specific characteristics of the 
disease and the patient (radiation therapy for plasmo-
cytoma, autologous bone marrow transplantation in 
young subjects, corticosteroid therapy or chemotherapy 
in the elderly). The usefulness of thalidomide and beva-
cuzimab in refractory POEMS syndromes remains to 
be seen.4,5 Most cases reports and series have described 
patients from Japon,6 China,7 and India.8 POEMS 
syndrome is rarely reported in Latin America,9-12 and 
then mostly in the form of case reports. This case, a 
Colombian male, is probably the first transplanted pa-
tient with POEMS syndrome on this continent. 
CASE 
A 44-year-old Colombian male was admitted on 
January 2004 for lumbar pain, paresthesias, and lower 
limb weakness for 10 months. He was referred for  an 
increase in abdominal girth and moderate dyspnea in 
recent weeks. He smoked and consumed liquor oc-
casionally, and had no history of exposure to toxic 
substances or a family history of neurological disease. 
Physical examination displayed alteration of proprio-
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ception and tactile sensitivity in the lower extremities, 
widespread arreflexia, muscle strength 4/5 in all seg-
ments, edema in the lower extremities, and white nails 
and clubbing, without splenomegaly. Laboratory results 
included CBC with thrombocytosis (571×109/L), C-
reactive protein of19 mg/L, TSH of 17.2 mIU/mL, 
low levels of vitamin B12 (130 pmol/L) and hypoal-
buminemia (34 g/L). Hepatic and renal function, and 
electrolytes, including calcium, were normal. A lumbar 
puncture showed increased protein (1.52 g/L), without 
cells or bacteria. Studies for HIV, HTLV1, hepatitis B 
and C were negative, as were studies for autoimmunity. 
The protein electrophoresis showed a modest monoclo-
nal gamma peak. A spinal CT scan showed only slight 
protrusion of the L5-S1, which did not explain neuro-
logical symptoms. He had an abdominal CT scan that 
evinced bilateral pleural effusion and ascites, without 
splenomegaly or hepatomegaly. The electromyography 
in four limbs demonstrated sensory-motor demyelinat-
ing polyneuropathy with dominance in the lower limbs. 
He was discharged with treatment for hypothyroidism 
and vitamin B12 deficiency. 
Seven months later he was assessed in the 
Endocrinology Outpatient Service. He had lost 10 ki-
lograms of weight. The weakness had progressed and 
he was unable to climb scales, hold objects in his hands 
or stand unaided. Physical examination revealed wide-
spread hyperpigmentation and a decrease in pubic hair. 
Orthostatic hypotension was found, and measurement 
of cortisol (71.7 nmol/L) confirmed the diagnosis of 
adrenal insufficiency. Polyendocrinopathy syndrome 
was diagnosed and treatment with prednisone and 
fludrocortisone was started. 
Twenty months after first consultation he was ad-
mitted by the emergency department for anasarca 
that compromised his breathing. On immunofixation 
electrophoresis an IgG lambda monoclonal peak was 
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detected (Figure 1A) with immunoglobulin levels of 
IgA: 0.297 g/L, IgG: 2.237 g/L and IgM: 0.178 g/L. 
Bence-Jones protein and cryoglobulins were negative. 
Echocardiography ruled out pulmonary hypertension 
and spirometry revealed a restrictive pattern: FVC of 
2.25 L (67% of predicted), FEV1 of 1.8 L (65% of pre-
dicted), and FEV1/FVC of 81. POEMS syndrome 
was diagnosed based on the following criteria: polyneu-
ropathy, monoclonal gammopathy IgG lambda, hypo-
thyroidism, adrenal failure, skin changes, extravascular 
overload (edema, ascites and pleural effusions), clubbing 
and white nails. He had no organomegaly, osteolytic or 
osteosclerotic lesions. A bone marrow study showed 
mild increased plasma cells. We started treatment with 
prednisone plus melphalan, levothyroxine, and vitamin 
B12. He was scheduled for high-dose chemotherapy 
followed by autologous peripheral blood stem cell 
transplantation (APBSCT). 
Six months after diagnosis he was conditioned with 
melphalan 200 mg/m2 and two autologous non-cryo-
preserved13 G-CSF mobilized bags were infused con-
taining 8.2×106 CD34/kg. He had a culture fever, with 
mild CRP elevation occurring on day +10, for which 
he received broad-spectrum antibiotic coverage. On 
day +5 we started G-CSF until sustained engraftment, 
which occurred on day +14 and he was discharged on 
day +22. Thirty months after the transplant the pa-
tient was totally autonomous, his neurological symp-
toms had completely improved and electromyography 
showed signs of active remyelinization. He had no ede-
ma, immunoelectrophresis was normal (Figure 1B) and 
spirometry showed significant lung function improve-
ment: FVC of 2.9 L (83% of predicted), FEV1 of 2.17 
L (73% of predicted) and FEV1/FVC of 73.1. 
DISCUSSION 
The diagnosis of Crow-Fukase syndrome is based on 
the presence of chronic sensori-motor polyneuropathy 
along with other characteristic generalized symptoms 
denoted by the acronym POEMS (polyneuropathy, or-
ganomegaly, endocrinopathy, monoclonal protein, and 
skin changes). Other features not initially described 
include elevated levels of vascular endothelial growth 
factor, sclerotic bone lesions, Castleman disease, papill-
edema, extravascular volume overload, thrombocytosis, 
polycythemia, fatigue and clubbing.5 Historically, thera-
pies for POEMS syndrome have included radiation, 
alkylator-based therapies and steroids, but in recent 
years the arsenal of treatments has expanded to include 
thalidomide, lenalidomide, high doses of melphalan 
with APBSCT and more recently the anti-vascular 
endothelial growth factor (VEGF) antibodies (bevaci-
zumab) with controversial results.14-16 Treatments with 
thalidomide or lenalidomide, and anti-VEGF mono-
clonal antibody (bevacizumab) should be considered as 
future therapies. Experience has shown that APBSCT 
is an effective therapy, with response rates above 90% al-
though patients with POEMS syndrome seem to have 
a high risk for an engraftment-type syndrome with high 
morbidity.17 
Our patient had severe disability secondary to the 
syndrome and was successfully treated with APBSCT. 
His transplant course was relatively unremarkable in 
that he did not develop engraftment syndrome and 
most importantly, remained asymptomatic 30 months 
after the transplant. There are no other reported cases 
of stem cell transplantation for treatment of POEMS 
syndrome in Latin America. 
Acknowledgment
Authors thank Dr Angela Dispenzieri from Department 
of Internal Medicine, Division of Hematology, Mayo 
Clinic, Rochester, MN, USA for her critical review and 
suggestions. 
B
 ELP                   G                  A                   m                   K                    L      ELP              G                   A                 m                 K                   L 
A
Figure 1. Immunofixation at time of diagnosis (A) and 26 months after the APBSCT (B).
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